10379-72-3 Usage
Uses
Used in Pharmaceutical Industry:
(3beta,20alpha)-3-hydroxy-11-oxoolean-12-en-29-oic acid is used as a pharmaceutical agent for its anti-inflammatory properties, which can help in managing inflammation-related conditions.
Used in Oncology:
In the field of oncology, (3beta,20alpha)-3-hydroxy-11-oxoolean-12-en-29-oic acid is utilized as an anti-tumor agent, targeting various types of cancer cells and potentially contributing to cancer treatment strategies.
Used in Fibrotic Disease Treatment:
(3beta,20alpha)-3-hydroxy-11-oxoolean-12-en-29-oic acid is applied as an anti-fibrotic agent, which may be beneficial in the treatment of fibrotic diseases by reducing tissue scarring and improving organ function.
Used in Diabetes and Obesity Research:
(3beta,20alpha)-3-hydroxy-11-oxoolean-12-en-29-oic acid is being investigated for its potential role in the treatment of diabetes and obesity, making it a valuable asset in the development of novel therapeutic approaches for metabolic disorders.
Used in Drug Development:
(3beta,20alpha)-3-hydroxy-11-oxoolean-12-en-29-oic acid serves as a key compound in drug development, with its unique structure and pharmacological activities being leveraged to create new medications for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 10379-72-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,3,7 and 9 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 10379-72:
(7*1)+(6*0)+(5*3)+(4*7)+(3*9)+(2*7)+(1*2)=93
93 % 10 = 3
So 10379-72-3 is a valid CAS Registry Number.
10379-72-3Relevant academic research and scientific papers
Acyclovir transdermal delivery system
-
, (2008/06/13)
A transdermal formulation for providing antiviral effect in dermis or epidermis, wherein comprising (a) 0.01 to 30 weight percent of antiviral drug; (b) 0.05 to 20 weight percent of a Chinese medicine enhancer; and (c) a pharmaceutical acceptable vehicles. The antiviral drug is selected from the group consisting of ACV(Acyclovir), Carbovir, DDA(2',3'-Dideoxyadnosine), HPMPA(1-(3-Hydroxy-2-phosphonylmethoxylpropyl)-adenosine), DHPG(Ganciclovir), Desciclovir, IDC (5-Iodo-2'-deoxy-cytidine), Vidarabine(Ara-A), DDI(2',3'-Dideoxyinosine), Cordycepin, Cytarabine, Deoxyguanosine, d4T(2',3'-Didehydro-3'-deoxythymidine), FIAC(2'-Fluoro-5-iodoaracytosine), AZT(ZDV, Zidovudine), Ara-T(1- beta -D-Ara-binofuranosylthymine), Deoxythymidine, Ribavirin, EDU(5-Ethyl-2'-deoxy-uridine), Enviroxime, Amantadine, Arildone, HPMPC(9-(3-Hydroxy-2-phosphonyl-methoxyl-propyl)cytidine), Riboxamide, Rimantidine, Tromantadine, Foscamet sodium, Moroxydine, F3T(5-Trifluoro-methyl-2'-deoxy-uridine), BVDU (Bromovinyldeoxyuridine). Preferably, the Chinese medicine enhancer is oleanolic acid, and the pharmaceutical acceptable vehicles is polyethylene glycols.
